Harrison Glassman, MD
Otolaryngology · Bronx, NYNPI 1811151608
Payments from drug & device makers
Across 261 payments — averaging $36.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$4K
- Sanofi$1K
- GSK$686
- Medical Device Business Services, Inc.$614
- Acclarent, Inc$341
- AstraZeneca$312
- plus $2K from 23 others
What the payments were for
- Consulting fees$2,50027%
- Travel & lodging$1,06211%
- Food & beverage$5,84162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 68 | $4,026 |
| Sanofi | 55 | $1,367 |
| GSK | 31 | $686 |
| Medical Device Business Services, Inc. | 1 | $614 |
| Acclarent, Inc | 13 | $341 |
| AstraZeneca | 18 | $312 |
| Neurent Medical Limited | 3 | $304 |
| Kaleo, Inc. | 13 | $248 |
| Medtronic(2 entities) | 9 | $247 |
| Regeneron Healthcare Solutions, Inc. | 10 | $196 |
| Stryker | 4 | $149 |
| Shire North American Group Inc | 1 | $111 |
| Intersect ENT, Inc. | 2 | $109 |
| Grifols USA, LLC | 6 | $94 |
| Integra Lifesciences Corporation | 1 | $92 |
| Alk-abello, Inc | 5 | $72 |
| Amgen | 3 | $65 |
| CSL Behring | 3 | $58 |
| Aerin Medical Inc. | 1 | $55 |
| Inspire Medical Systems, Inc. | 2 | $54 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Merck | 2 | $32 |
| AbbVie | 2 | $28 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $17 |
| Incyte Corporation | 1 | $15 |
| Pfizer | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$2,853
- NEUROMARK System$276
- NEUROMARK Radiofrequency Console$276
- XIIDRA$111
- TruDi Nav Cable$105
How this compares
$9,403 in reported general payments places this provider in the 85th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 33 | $34,095 |
| Fluticasone Propionate | 121 | $814 |
| Methylprednisolone | 47 | $305 |
| Ipratropium Bromide | 13 | $284 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $268 |
| Clarithromycin | 17 | $245 |
| Omeprazole | 15 | $196 |
| Azelastine Hcl | 21 | $195 |
| Amoxicillin | 23 | $94 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $70 |
| Prednisone | 18 | $42 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $4,026 | $34,09533 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 701 otolaryngology providers in New York.
Other otolaryngology in Bronx
- Ronda AlexanderBronx$37K
- Robert KellmanSyracuse$2.5M
- Anthony DelsignoreNew York$966K
- Roheen RaithathaNew York$882K
- Dennis KrausNew York$524K
- Ashutosh KackerNew York$387K
- Lawrence LustigNew York$383K
- Brett MilesNew York$368K
- Alfred Marc IloretaNew York$342K
- Nora PerkinsAlbany$315K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.